United States · FDA National Drug Code directory
INVOKANA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-4364_8f7706b7-8c1b-4c13-bb18-3ec25c98425f
- Product NDC
- 50090-4364
- Form
- TABLET, FILM COATED
- Composition / generic term
- canagliflozin
- Labeler
- A-S Medication Solutions
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130329
- Source listing expiry
- 20261231
Source-listed ingredients
- CANAGLIFLOZIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET, FILM COATED in 1 BOTTLE (50090-4364-0) · 50090-4364-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →